Juan Horcajada to Aged, 80 and over
This is a "connection" page, showing publications Juan Horcajada has written about Aged, 80 and over.
Connection Strength
0.114
-
Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients? Molecules. 2019 Feb 01; 24(3).
Score: 0.022
-
High-dose daptomycin together with rifampin as salvage therapy for prosthetic joint infections. Med Clin (Barc). 2017 09 08; 149(5):223-224.
Score: 0.020
-
Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa. BMC Infect Dis. 2017 01 05; 17(1):11.
Score: 0.019
-
Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate. Int J Antimicrob Agents. 2016 Dec; 48(6):725-727.
Score: 0.019
-
COVID-19 in Grade 4-5 Chronic Kidney Disease Patients. Kidney Blood Press Res. 2020; 45(5):768-774.
Score: 0.006
-
Comorbidities and Mortality in Patients With COVID-19 Aged 60 Years and Older in a University Hospital in Spain. Arch Bronconeumol (Engl Ed). 2020 Nov; 56(11):756-758.
Score: 0.006
-
Linezolid Dosing in Patients With Liver Cirrhosis: Standard Dosing Risk Toxicity. Ther Drug Monit. 2019 12; 41(6):732-739.
Score: 0.006
-
Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia. J Antimicrob Chemother. 2019 11 01; 74(11):3268-3273.
Score: 0.006
-
Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections. Antimicrob Agents Chemother. 2017 08; 61(8).
Score: 0.005
-
Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study. BMC Infect Dis. 2012 Oct 05; 12:245.
Score: 0.004